ClinicalTrials.Veeva

Menu
S

Sutter Health | Center of Excellence in Diabetes and Endocrinology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ertugliflozin
PF-04971729
BMF-219
Tirzepatide
MK-8835
MK-8835-059

Parent organization

This site is a part of Sutter Health

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 3 total trials

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

The goal of the study is to assess how tirzepatide impacts bodyweight and cardiovascular risk factors when used in conjunction with healthy nutrition...

Not yet enrolling
Weight Gain
Obesity
Drug: Tirzepatide
Drug: Placebo

This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. Th...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Metformin
Drug: Placebo to ertugliflozin 5 mg

Trial sponsors

B
Lilly logo
Merck Sharp & Dohme (MSD) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems